Structure Therapeutics to Participate in Two Upcoming Healthcare Investor Conferences
Structure Therapeutics (NASDAQ: GPCR), a clinical-stage biopharmaceutical company focused on developing oral small molecule therapeutics for metabolic diseases and obesity, has announced its participation in two major healthcare investor conferences.
Management will present at the Cantor Global Healthcare Conference on September 3 at 3:55 p.m. ET and the Morgan Stanley 23rd Annual Global Healthcare Conference on September 10 at 10:45 a.m. ET. Both events will be held in New York and will feature fireside chats along with one-on-one meetings. Webcasts will be available on the company's investor relations website for 90 days.
Structure Therapeutics (NASDAQ: GPCR), azienda biofarmaceutica in fase clinica focalizzata sullo sviluppo di farmaci orali a piccola molecola per le malattie metaboliche e l'obesità, ha annunciato la propria partecipazione a due importanti conferenze per investitori nel settore sanitario.
La direzione presenterà al Cantor Global Healthcare Conference il 3 settembre alle 15:55 ET e al Morgan Stanley 23rd Annual Global Healthcare Conference il 10 settembre alle 10:45 ET. Entrambi gli eventi si terranno a New York e prevedono conversazioni informali e incontri one-to-one. I webcast saranno disponibili sul sito degli investor relations della società per 90 giorni.
Structure Therapeutics (NASDAQ: GPCR), una compañía biofarmacéutica en fase clínica centrada en desarrollar terapias orales de pequeña molécula para enfermedades metabólicas y la obesidad, ha anunciado su participación en dos importantes conferencias para inversores del sector salud.
La dirección presentará en el Cantor Global Healthcare Conference el 3 de septiembre a las 3:55 p.m. ET y en el Morgan Stanley 23rd Annual Global Healthcare Conference el 10 de septiembre a las 10:45 a.m. ET. Ambos eventos se celebrarán en Nueva York e incluirán charlas informales y reuniones uno a uno. Las retransmisiones web estarán disponibles en la web de relaciones con inversores de la compañía durante 90 días.
Structure Therapeutics (NASDAQ: GPCR)는 대사 질환 및 비만 치료용 경구용 소분자 약물을 개발하는 임상 단계 바이오제약사로, 두 건의 주요 헬스케어 투자자 콘퍼런스에 참가한다고 발표했습니다.
경영진은 Cantor Global Healthcare Conference에서 9월 3일 오후 3시 55분(ET)에, Morgan Stanley 23rd Annual Global Healthcare Conference에서 9월 10일 오전 10시 45분(ET)에 발표를 진행합니다. 두 행사는 모두 뉴욕에서 열리며, 파이어사이드 토크와 일대일 미팅이 마련됩니다. 웹캐스트는 회사 투자자 관계 웹사이트에서 90일간 제공됩니다.
Structure Therapeutics (NASDAQ: GPCR), une société biopharmaceutique en phase clinique spécialisée dans le développement de traitements oraux à petites molécules pour les maladies métaboliques et l'obésité, a annoncé sa participation à deux grandes conférences pour investisseurs dans le secteur de la santé.
La direction présentera au Cantor Global Healthcare Conference le 3 septembre à 15h55 ET et au Morgan Stanley 23rd Annual Global Healthcare Conference le 10 septembre à 10h45 ET. Les deux événements se tiendront à New York et comprendront des entretiens informels ainsi que des réunions en tête‑à‑tête. Les webcasts seront disponibles sur le site des relations investisseurs de la société pendant 90 jours.
Structure Therapeutics (NASDAQ: GPCR), ein biopharmazeutisches Unternehmen in klinischer Phase, das sich auf die Entwicklung oraler niedermolekularer Therapeutika für Stoffwechselerkrankungen und Adipositas konzentriert, hat seine Teilnahme an zwei bedeutenden Healthcare-Investorenkonferenzen angekündigt.
Das Management wird auf der Cantor Global Healthcare Conference am 3. September um 15:55 Uhr ET und auf der Morgan Stanley 23rd Annual Global Healthcare Conference am 10. September um 10:45 Uhr ET präsentieren. Beide Veranstaltungen finden in New York statt und umfassen Fireside-Chats sowie Einzelgespräche. Webcasts sind für 90 Tage auf der Investor-Relations-Website des Unternehmens verfügbar.
- None.
- None.
SAN FRANCISCO, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic diseases, with a focus on obesity, today announced that management will participate in two upcoming healthcare conferences in September.
| Cantor Global Healthcare Conference | ||
| Format: | Fireside chat and 1x1 meetings | |
| Date/time: | Wednesday, September 3 at 3:55 p.m. ET | |
| Location: | New York, NY | |
Morgan Stanley 23rd Annual Global Healthcare Conference | ||
| Format: | Fireside chat and 1x1 meetings | |
| Date/time: | Wednesday, September 10 at 10:45 a.m. ET | |
| Location: | New York, NY | |
The live and archived webcasts will be accessible from the company’s website at https://ir.structuretx.com/events-presentations/events and replays will be available for 90 days.
About Structure Therapeutics
Structure Therapeutics is a science-driven clinical-stage biopharmaceutical company focused on discovering and developing innovative oral small molecule treatments for chronic metabolic and cardiopulmonary conditions with significant unmet medical needs. Utilizing its next generation structure-based drug discovery platform, the Company has established a robust GPCR-targeted pipeline, featuring multiple wholly-owned proprietary clinical-stage oral small molecule compounds designed to surpass the scalability limitations of traditional biologic and peptide therapies and be accessible to more patients around the world. For additional information, please visit www.structuretx.com.
Investors:
Danielle Keatley
Structure Therapeutics Inc.
ir@structuretx.com
Media:
Dan Budwick
1AB
Dan@1abmedia.com
FAQ
When is Structure Therapeutics (GPCR) presenting at the Cantor Global Healthcare Conference?
When is Structure Therapeutics (GPCR) presenting at the Morgan Stanley Healthcare Conference?
How can investors access Structure Therapeutics' (GPCR) conference presentations?
What type of company is Structure Therapeutics (GPCR)?
